William B Hillegass

William B Hillegass

UNVERIFIED PROFILE

Are you William B Hillegass?   Register this Author

Register author
William B Hillegass

William B Hillegass

Publications by authors named "William B Hillegass"

Are you William B Hillegass?   Register this Author

94Publications

803Reads

20Profile Views

Prior probability of significant obstructive arterial disease in the contralateral lower extremity.

Catheter Cardiovasc Interv 2020 Feb;95(2):307-308

Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28748DOI Listing
February 2020

Clopidogrel pretreatment may reduce early acquired thrombocytopenia after transcatheter aortic valve replacement (TAVR).

Catheter Cardiovasc Interv 2019 Nov;94(6):818-819

Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28569DOI Listing
November 2019

Costs of postoperative delirium with transcatheter aortic valve replacement: Improved yet still present.

Catheter Cardiovasc Interv 2019 May;93(6):1137

Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28276DOI Listing
May 2019

Intravascular ultrasound of normal left main arteries: Insights for stent optimization and standardization.

Catheter Cardiovasc Interv 2019 02;93(2):239-240

University of Alabama at Birmingham Cardiovascular Division, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28077DOI Listing
February 2019

Embolic stroke of undetermined source and patent foramen ovale closure: Practice insights from meta-analysis?

Catheter Cardiovasc Interv 2018 11;92(6):1161-1162

Division of Cardiovascular Disease, The University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27964DOI Listing
November 2018

"Expanding the frame" for valve-in-valve therapy in small bioprostheses: Encouraging signs for the road ahead.

Catheter Cardiovasc Interv 2018 09;92(3):555-556

Division of Cardiovascular Disease, The University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ccd.27801
Publisher Site
http://dx.doi.org/10.1002/ccd.27801DOI Listing
September 2018

Surgical aortic valve replacement and transcatheter aortic valve implantation for severe aortic stenosis: Equipoise remains a tenable assumption.

Catheter Cardiovasc Interv 2018 08;92(2):431-432

Division of Cardiovascular Disease, The University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27772DOI Listing
August 2018

Patent foramen ovale closure for cryptogenic stroke: Effective, but only in select patients.

Catheter Cardiovasc Interv 2018 07;92(1):174-175

Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27700DOI Listing
July 2018

Anticoagulation Control in Patients With Ventricular Assist Devices.

ASAIO J 2017 Nov/Dec;63(6):759-765

From the *Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama; †Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama; ‡Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; §Division of Cardiovascular Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; ¶Division of Cardiothoracic Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama; ‖Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama; and #Heart South Cardiovascular Group, Columbiana, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAT.0000000000000592DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662489PMC
May 2018

Long-term survival prospects of patients undergoing percutaneous coronary intervention: Envisioning the future.

Catheter Cardiovasc Interv 2018 03;91(4):696

Cardiovascular Division and Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27560DOI Listing
March 2018

The promise of effective P2Y platelet receptor pretreatment: Not crushed yet.

Catheter Cardiovasc Interv 2018 02;91(2):251-252

Cardiovascular Division, University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27512DOI Listing
February 2018

Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.

JACC Cardiovasc Interv 2018 01 1;11(2):181-191. Epub 2017 Nov 1.

Department of Pharmacotherapy and Translational Research, University of Florida, Gainesville, Florida; Department of Medicine, Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2017.07.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775044PMC
January 2018

Patient preference: An important emerging factor in operator access site selection.

Catheter Cardiovasc Interv 2018 01;91(1):25-26

Cardiovascular Division, University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27457DOI Listing
January 2018

Individualizing dual antiplatelet therapy duration: Prediction tools, genomics, and clinical judgment.

Catheter Cardiovasc Interv 2017 07;90(1):38

Cardiovascular Division, University of Alabama at Birmingham.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27166DOI Listing
July 2017

Length and pressure matter: Expediting evidence-based progress in femoropoliteal intervention.

Catheter Cardiovasc Interv 2017 06;89(7):1257-1258

University of Alabama at Birmingham Cardiovascular Division, Birmingham, AL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27131DOI Listing
June 2017

The many radial access learning curves.

Catheter Cardiovasc Interv 2017 04;89(5):865-866

Heart South Cardiovascular Group, Alabaster, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27046DOI Listing
April 2017

Unprotected Left Main Disease and Percutaneous Intervention: A Prototype for Precision Medicine.

Catheter Cardiovasc Interv 2017 01;89(1):11-12

Department of Biostatistics, University of Alabama at Birmingham, Birmingham and Alabaster, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.26893DOI Listing
January 2017

Radial Access Optimization in the Nascent Post-Adoption Era.

Catheter Cardiovasc Interv 2016 12;88(7):1044-1045

Heart South Cardiovascular Group, Alabaster, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.26864DOI Listing
December 2016

Risk guided use of the direct thrombin inhibitor bivalirudin: insights from recent trials and analyses.

J Thorac Dis 2016 Sep;8(9):E1034-E1040

Heart South Cardiovascular Group, Brookwood Shelby Baptist Medical Center, Department of Biostatistics, University of Alabama at Birmingham, Alabaster and Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2016.08.79DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059288PMC
September 2016

End of the bare metal stent era?

Catheter Cardiovasc Interv 2016 07;88(1):49-50

Heart South Cardiovascular Group and Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.26640DOI Listing
July 2016

Valvular Heart Disease and Acquired Type 2A von Willebrand Syndrome: The "Hemostatic" Waring Blender Syndrome.

JAMA Cardiol 2016 05;1(2):205-6

Hugh Kaul Personalized Medicine Institute, Departments of Neurology and Epidemiology, University of Alabama at Birmingham, Alabaster and Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamacardio.2016.0182DOI Listing
May 2016

Risk-guided use of the direct thrombin inhibitor bivalirudin.

Catheter Cardiovasc Interv 2016 Feb;87(3):401-2

Heart South Cardiovascular Group, Alabaster, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.26441DOI Listing
February 2016

Insulin-treated diabetes mellitus: An important, actionable risk marker after coronary stenting.

Catheter Cardiovasc Interv 2016 Jan;87(1):63-4

Heart South Cardiovascular Group, Department of Biostatistics, University of Alabama at Birmingham, Alabaster and Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.26385DOI Listing
January 2016

Diabetes is not sufficient justification for IIb/IIIa use in percutaneous coronary intervention.

Catheter Cardiovasc Interv 2015 Sep;86(3):376-7

Heath South Cardiovascular Group, Alabaster, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.26130DOI Listing
September 2015

Renal artery stenting: patient selection post-CORAL.

Catheter Cardiovasc Interv 2015 Aug;86(2):310-1

Heart South Cardiovascular Group, Alabaster, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.26090DOI Listing
August 2015

Obesity and percutaneous coronary intervention outcomes: beware the extremes.

Catheter Cardiovasc Interv 2015 May;85(6):959-60

Heart South Cardiovascular Group, Alabaster, Alabama; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.25933DOI Listing
May 2015

Percutaneous coronary intervention: ever closer to real world silver bullets!?

Catheter Cardiovasc Interv 2015 Apr;85(5):807-8

Interventional Cardiovascular Section, Heart South Cardiovascular Group, Alabaster, Alabama; Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.25885DOI Listing
April 2015

Can femoral access bleeding outcomes be improved?

Catheter Cardiovasc Interv 2015 Feb;85(3):380-1

Heart South Cardiovascular Group, Alabaster, Alabama; University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.25808DOI Listing
February 2015

Optimal DAPT duration: each in their own time.

Catheter Cardiovasc Interv 2015 Jan;85(1):41-2

Heart South Cardiovascular Group, Alabaster, AL and University of Alabama at Birmingham, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.25737DOI Listing
January 2015

Republished: The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis.

Postgrad Med J 2014 Dec;90(1070):722-9

Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/postgradmedj-2013-204715repDOI Listing
December 2014

The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis.

Ann Rheum Dis 2014 Jul 5;73(7):1301-8. Epub 2014 May 5.

Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2013-204715DOI Listing
July 2014

The learning curve for transradial percutaneous coronary intervention among operators in the United States: a study from the National Cardiovascular Data Registry.

Circulation 2014 Jun 22;129(22):2277-86. Epub 2014 Apr 22.

From the Duke Clinical Research Institute, Durham, NC (C.N.H., E.D.P., M.L.N., D.D., M.W.K., S.V.R.); University of Alabama at Birmingham, Birmingham, AL (W.B.H.); Wake Forest University School of Medicine, Winston-Salem, NC (M.A.K.); University of Colorado, Denver, CO (J.C.M.); The Wright Center for Graduate Medical Education, Scranton, PA (S.P.); Vanderbilt Heart Center, Nashville, TN (R.N.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.113.006356DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048735PMC
June 2014

Thromboaspiration and IIb/IIIa therapy in STEMI: abciximab redux?

Catheter Cardiovasc Interv 2013 Oct;82(4):612-3

Heart South Cardiovascular Group, Alabaster, Alabama; University of Alabama at Birmingham, Birmingham, Alabama.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.25156DOI Listing
October 2013

Stent paleology: diabetic lessons from extinct stents.

Catheter Cardiovasc Interv 2013 Jun;81(7):1125-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.24963DOI Listing
June 2013

Diabetes and everolimus-eluting stents: good offense scores but defense wins tough games.

Catheter Cardiovasc Interv 2013 Apr;81(5):766-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.24893DOI Listing
April 2013

Saphenous vein grafts: two substrates, two treatments?

Catheter Cardiovasc Interv 2012 Dec;80(7):1137

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.24715DOI Listing
December 2012

Benefit of renal artery stenting: is on-target therapy the observational bias?

Catheter Cardiovasc Interv 2012 Sep;80(3):351

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.24570DOI Listing
September 2012

Rotational atherectomy for heavily calcified unprotected left main disease: proceed with caution.

Catheter Cardiovasc Interv 2012 Aug;80(2):221

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.24525DOI Listing
August 2012

Implicit rationing of percutaneous coronary intervention: the left main test case.

Catheter Cardiovasc Interv 2012 Jun;79(7):1117

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.24465DOI Listing
June 2012

Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview.

Vasc Health Risk Manag 2011 18;7:445-59. Epub 2011 Jul 18.

Columbiana Cardiovascular Consultants, Columbiana, AL 35051, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/VHRM.S4746DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148418PMC
December 2011

Diabetes and percutaneous coronary intervention drug-eluting: stents whenever feasible.

Catheter Cardiovasc Interv 2011 Nov;78(5):718-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.23381DOI Listing
November 2011

Shock and age: the role of an early invasive strategy.

Catheter Cardiovasc Interv 2011 Oct;78(4):512-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.23357DOI Listing
October 2011

A full toolbox fixes the roadblocks.

Catheter Cardiovasc Interv 2011 Apr;77(5):759-60

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.23068DOI Listing
April 2011

ACP Journal Club. Review: Third-generation P2Y12 inhibitors reduce mortality after PCI more than clopidogrel.

Ann Intern Med 2011 Mar;154(6):JC3-6

University of Alabama at Birmingham, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-154-6-201103150-02006DOI Listing
March 2011

DES in SVGs: safe and at least short-term effective.

Catheter Cardiovasc Interv 2011 Feb;77(3):356-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.22972DOI Listing
February 2011

High glycemic stenting menu.

Catheter Cardiovasc Interv 2010 Dec;76(7):934-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.22887DOI Listing
December 2010

Drug-eluting or bare metal stents for diabetics: clinical judgment still wins.

Catheter Cardiovasc Interv 2010 Oct;76(4):482-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.22774DOI Listing
October 2010

The Holy Grail for DES: does efficacy translate into real world effectiveness?

Catheter Cardiovasc Interv 2010 Sep;76(3):381-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.22749DOI Listing
September 2010

Which DES for diabetics? Round 1: A draw. Round 2: Everolimus leading?

Catheter Cardiovasc Interv 2010 Jul;76(1):58-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.22678DOI Listing
July 2010

Bifurcation stenting: a commitment to always kiss.

Catheter Cardiovasc Interv 2010 Mar;75(4):614-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.22486DOI Listing
March 2010

Length matters: outcomes of superficial femoral artery (SFA) endovascular interventions.

Catheter Cardiovasc Interv 2009 Dec;74(7):1096

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.22337DOI Listing
December 2009

As goes the access, so goes the intervention?

Catheter Cardiovasc Interv 2009 Nov;74(6):932-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.22312DOI Listing
November 2009

The modern axis of peri-procedural evil.

Catheter Cardiovasc Interv 2009 Jul;74(1):56-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.22136DOI Listing
July 2009

ACP Journal Club. Prasugrel prevented ischemic events compared with clopidogrel in patients having PCI for STEMI.

Ann Intern Med 2009 Jun;150(12):JC6-10

University of Alabama at Birmingham, Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-150-12-200906160-02010DOI Listing
June 2009

A third dimension to uncloud the funnel plot of operator quality.

Catheter Cardiovasc Interv 2009 Apr;73(5):595-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.22039DOI Listing
April 2009

Pretreatment with nitroprusside for microcirculatory protection in saphenous vein graft interventions.

J Invasive Cardiol 2009 Feb;21(2):34-9

Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL 35294-0012, USA.

View Article

Download full-text PDF

Source
February 2009

Clinical significance of post-procedural TIMI flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention.

JACC Cardiovasc Interv 2009 Jan;2(1):56-64

Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27715, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcin.2008.10.006DOI Listing
January 2009

Vascular changes and black hole phenomenon after coronary brachytherapy: a pathologically distinct entity.

J Invasive Cardiol 2008 Oct;20(10):560-2

Department of Medicine, University of Tennessee Health Science Center, 1211 Union Avenue, Suite 340, Memphis, TN 38104, USA.

View Article

Download full-text PDF

Source
October 2008

Prasugrel reduced ischemic outcomes more than did clopidogrel in patients receiving stents for ACS.

ACP J Club 2008 Sep;149(3):12

University of Alabama at Birmingham, Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
September 2008

DES in saphenous bypass grafts: A treatment in vain?

Catheter Cardiovasc Interv 2008 Jul;72(1):21-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.21649DOI Listing
July 2008

Review: late percutaneous coronary intervention after AMI improves survival more than optimal medical therapy.

ACP J Club 2008 Jul;149(1)

University of Alabama at Birmingham, Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
July 2008

Aspirin was cost-effective for primary prevention of cardiovascular events in older women at moderate risk.

ACP J Club 2007 Jul-Aug;147(1):24

University of Alabama, Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
August 2007

Urgent revascularization with PCI was more cost-effective than CABG in medically refractory, high-risk myocardial ischemia.

ACP J Club 2007 Mar-Apr;146(2):49

University of Alabama at Birmingham, Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
April 2007

Ruptured giant right coronary artery aneurysm percutaneously plugged.

J Invasive Cardiol 2007 Mar;19(3):139-41

Interventional Cardiovascular Section, Cardiovascular Division, University of Alabama at Birmigham, Birmingham, AL 35294-0012, USA.

View Article

Download full-text PDF

Source
March 2007

First human case description of TandemHeart-assisted high-risk percutaneous balloon aortic valvuloplasty using bivalirudin anticoagulation.

J Invasive Cardiol 2007 Jan;19(1):E5-8

University of Alabama at Birmingham, Birmingham, AL 35205, USA.

View Article

Download full-text PDF

Source
January 2007

Severe, diffuse coronary artery spasm after drug-eluting stent placement.

J Invasive Cardiol 2006 Dec;18(12):584-92

The University of Alabama at Birmingham, Interventional Cardiology, BDB 383, 1808 7th Avenue South, Birmingham, AL 35294, USA.

View Article

Download full-text PDF

Source
December 2006

Rescue angioplasty reduced cardiovascular and cerebrovascular outcomes in acute MI after failed thrombolytic therapy.

ACP J Club 2006 May-Jun;144(3):60-1

University of Alabama at Birmingham, Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
May 2006

Review: evidence supporting reduced death and reinfarction by percutaneous coronary intervention after thrombolysis is inconclusive.

ACP J Club 2006 May-Jun;144(3):60-1

University of Alabama at Birmingham, Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
May 2006

Prophylactic implantable cardioverter-defibrillators increased life expectancy with an acceptable cost-effectiveness ratio.

ACP J Club 2006 Mar-Apr;144(2):52

University of Alabama at Birmingham, Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
March 2006

Invasive strategy within 24 hours of thrombolysis reduced death, nonfatal reinfarction, and ischemia-induced revascularization in STEMI.

ACP J Club 2005 Mar-Apr;142(2):38

University of Alabama at Birmingham,, Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
April 2005

PCI with bivalirudin and provisional GP IIb/IIIa inhibition is more cost-effective than heparin plus routine GP IIb/IIIa inhibition. Commentary.

Evid Based Cardiovasc Med 2005 Mar;9(1):68-71

University of Alabama at Birmingham, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebcm.2005.01.008DOI Listing
March 2005

Cypher drug-eluting stent treatment of tibioperoneal obstructive disease: a case report.

Catheter Cardiovasc Interv 2005 Feb;64(2):237-41

Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.20255DOI Listing
February 2005

High-dose atorvastatin was superior to standard-dose pravastatin for reducing death or major cardiovascular events in acute coronary syndromes.

ACP J Club 2004 Sep-Oct;141(2):33

University of Alabama at Birmingham, Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
September 2004

Long-term follow-up of brachytherapy for treatment of allograft in-stent restenosis.

Catheter Cardiovasc Interv 2004 Feb;61(2):217-21

Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.10689DOI Listing
February 2004

Review: low-molecular-weight heparin is effective and safe in the acute coronary syndromes.

ACP J Club 2003 Nov-Dec;139(3):58

University of Alabama at Birmingham, Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
December 2003

Treatment of in-stent restenosis in a gastroepiploic artery coronary bypass graft with brachytherapy.

J Invasive Cardiol 2003 Nov;15(11):677-80

University of Alabama at Birmingham, Division of Cardiovascular Disease, Birmingham, AL 35294-0012, USA.

View Article

Download full-text PDF

Source
November 2003

An early invasive strategy reduced death, myocardial infarction, and hospital readmissions at 2 years in unstable CAD.

ACP J Club 2003 Sep-Oct;139(2):30

University of Alabama at Birmingham, Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
October 2003

An interventional strategy was better than a conservative strategy in unstable angina or non-ST-elevation MI.

ACP J Club 2003 Mar-Apr;138(2):32

University of Alabama at Birmingham, Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
March 2003

Cardiac resynchronization was effective for moderate-to-severe heart failure with intraventricular conduction delay.

ACP J Club 2002 Nov-Dec;137(3):82

University of Alabama at Birmingham, Birmingham, Alabama, USA.

View Article

Download full-text PDF

Source
February 2003